ALS breakthrough: Synapse-regenerating pill moves to phase 2 human trials

A unique once-a-day pill to treat ALS has been approved for ongoing clinical trials

Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, affects nerve cells in the brain and spinal cord, called motor neurons, that control voluntary muscle movements like walking, talking, and breathing. As the neurons die and can’t send messages to the muscles, loss of muscle control worsens over time and is eventually fatal.

Continue Reading

Category: Medical, Science

Tags: , ,

Comentarios

Entradas más populares de este blog

Paddock Paradise focuses on storage and comfort – for people and cats